April MindMatters
ABTA PARTNERS WITH THE FDA AND BRAIN TUMOR COMMUNITY TO EVALUATE AND ADVANCE CLINICAL DEVELOPMENT OF BRAIN METASTASES TREATMENTS Approximately 200,000 cancer patients are diagnosed with brain metastases every year.
ABTA PARTNERS WITH THE FDA AND BRAIN TUMOR COMMUNITY TO EVALUATE AND ADVANCE CLINICAL DEVELOPMENT OF BRAIN METASTASES TREATMENTS Approximately 200,000 cancer patients are diagnosed with brain metastases every year.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631